期刊文献+

转化生长因子β1基因T869C、G915C和C788T多态性与贲门腺癌发病风险的关系 被引量:2

Correlation of TGF-β1 T869C,G915C and C788T polymorphisms to the risk of gastric cardia adenocarcinoma
下载PDF
导出
摘要 目的:探讨转化生长因子β1(transforming growth factorβ1,TGF-β1)基因T869C、G915C和C788T单核苷酸多态性与中国北方人群贲门腺癌(gastric cardia adenocarcinoma,GCA)遗传易感性的关系。方法:采用PCR-RFLP方法检测214名GCA患者和298名健康对照的TGF-β1基因T869C、G915C和C788T多态性分布情况,同时采用ELISA方法检测血清TGF-β1水平,对110例GCA患者手术切除的肿瘤组织采用免疫组织化学方法检测TGF-β1蛋白表达。结果:TGF-β1基因T869C多态性位点的基因型和等位基因型频率在贲门腺癌组和对照组间的分布差异有统计学意义(P〈0.05),GCA患者组C等位基因型频率(55.8%)显著高于对照组(45.8%)(P〈0.01),C等位基因携带者患贲门腺癌的风险是T等位基因的1.50倍(经性别、年龄和上消化道肿瘤家族史校正后的OR=1.50,95%CI为1.17(2.11),与TT基因型相比,携带TC和CC基因型可显著增加GCA的发病风险(校正后的OR分别为1.91和2.18,95%CI分别为1.34~2.41和1.56~2.71)。TGF-β1基因G915C和C788T多态性位点的基因型及等位基因型频率在GCA患者组和对照组之间,其总体分布差异均无统计学意义(P〉0.05)。贲门腺癌患者血浆TGF-β1水平显著高于对照组(P〈0.01),携带T869C位点C等位基因的GCA患者血浆TGF-β1水平显著高于非携带者(P〈0.05)。贲门腺癌组织中TGF-β1蛋白阳性表达率(65.5%)显著高于癌旁组织(15.5%)(P〈0.01),携带T869C位点C等位基因的GCA患者TGF-β1蛋白阳性表达率高于非携带者(P〈0.05)。结论:TGF-β1T869C位点C等位基因可能是我国北方人群贲门腺癌的遗传易感基因,携带C等位基因的个体可能通过促进TGF-β1的高度表达进而增加了贲门腺癌的发病风险。 OBJECTIVE:To investigate the possible association of the transforming growth factor β1(TGF-β1)gene T869C,G915C and C788T polymorphisms with susceptibility to gastric cardia adenocarcinoma(GCA)in a population of North China.METHODS:Polymerase-chain reaction-restriction fragment length polymorphism(PCR-RFLP)method was used to detect the genotype of T869C,G915C and C788T single nucleotide polymorphisms(SNPs)in 214 GCA patients and 298 healthy controls.The level of TGF-β1 was measured by ELISA and the protein expression of TGF-β1 in tumors and corresponding normal tissues was detected by immunohistochemistry method.RESULTS:The overall genotype and allelotype distributions of TGF-β1 T869C polymorphism in GCA patients were significantly different from that in healthy controls(P〈0.05).The frequency of C allelotype was significantly higher in GCA patients than that in healthy controls(55.8% vs.45.8%,P〈0.01),the C allelotype significantly increased the risk of developing GCA [adjusted odds ratio(OR)=1.50,95% confidence interval(CI)=1.17-2.11].Compared with TT genotype,the TC and CC genotypes significantly enhanced the risk of developing GCA(adjusted OR=1.91 and 2.18,respectively;95%CI=1.34-2.41 and 1.56-2.71,respectively).The genotype and allelotype distributions of TGF-β1 G915C and C788T polymorphism in GCApatients were not significantly different from that in healthy controls(P〈0.05).The level of TGF-β1 was higher in GCA patients than that in healthy controls(P〈0.01)and GCA patients with C allelotype of T869C site were higher than that without C allelotype(P〈0.05).The protein expression of TGF-β1 in GCA tumor tissues(65.5%)was significantly higher than that in corresponding normal tissues(15.5%)(P〈0.01)and GCA patients with C allelotype of T869C site were higher than that without C allelotype(P〈0.05).CONCLUSION:C allelotype of TGF-β1 T869C may be one of the factors that affects the risk of developing GCA in north China and C allelotype carriers may be at increased risk of GCA by enhancing the TGF-β1 expression.
出处 《癌变.畸变.突变》 CAS CSCD 2010年第4期255-260,共6页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 河北省医学科学研究重点课题计划(20090465)
关键词 转化生长因子Β1 单核苷酸多态性 贲门腺癌 肿瘤易感性 transforming growth factor β1 polymorphism gastric cardia adenocarcinoma susceptibility
  • 相关文献

参考文献3

二级参考文献16

  • 1Wong SF,Lai LC.The role of TGF beta in human cancers.Pathol,2001,33:85-92.
  • 2Dunning AM,Ellis PD,McBride S,et al.A transforming growth factor beta 1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer.Cancer Res,2003,63:2610-2615.
  • 3Li Z,Habuchi T,Tsuchiya N,et al.Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.Carcinogenesis,2004,25:237-240.
  • 4KimYJ,Lee HS,ImJP,et al.Association of transforming growth factorbeta 1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.Exp Mol Med,2003,35:196-202.
  • 5Stanczuk GA,Tswana SA,Bergstrom S,et al.Polymorphism in codons 10 and 25 of the transforming growth factor-beta 1 (TGF-beta 1) gene in patients with invasive squamous cell carcinoma of the uterine cervix.Eur J Immunogenet,2002,29:417-421.
  • 6Fukuchi M,Masuda N,Miyazaki T,et al.Decreased Smad 4 expression in the transforming growth factor-beta signaling pathway during progression of esophageal squamous cell carcinoma.Cancer,2002,95:737-743.
  • 7Lijnen PJ,Petrov VV,Fagard RH.Association between transforming growth factor-beta and hypertension[J].Am J Hypertens,2003 ;16:604-11.
  • 8Wu L,Chau J,Young RP,et al.Transforming growth factor-beta1 genotype and susceptibility to chronic obstructive pulmonary disease[J].Thorax,2004 ;59:126-9.
  • 9Suzuki S,Tanaka Y,Orito E,et al.Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection[J].Gastroenterol Hepatol,2003; 18:1139 -43.
  • 10Stanczuk GA,Tswana SA,Bergstrom S,et al.Polymorphism in codons 10 and 25 of the transforming growth factor-beta 1 (TGF-beta1) gene in patients with invasive squamous cell carcinoma of the uterine cervix[J].Eur J Immunogenet,2002 ;29:417-21.

共引文献15

同被引文献35

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部